Stay updated with breaking news from Collaborative Registration Procedure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The National Agency for Food and Drug Administration Control (NAFDAC), has granted registration approval for the R21 Malaria Vaccine (Recombinant, Adjuvanted), manufactured by Serum Institute of India Limited.
NAFDAC has approved R21 Malaria Vaccine with the potency of preventing malaria infection in children aged five to 36 months.
Team Lead, Facilitated Product Introduction, Geneva, Switzerland Organization: World Health Organization (WHO) Country: Switzerland City: Geneva Office: WHO...